Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
DNA fragments released from cancer cells into the blood can be used to generate molecular profiles of tumors. Non-invasive 'liquid biopsies' can be used to monitor minimal residual disease and detect the emergence of drug resistance.
Alternative Titles
Full title
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2000539545
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2000539545
Other Identifiers
ISSN
1474-760X
E-ISSN
1474-760X
DOI
10.1186/s13059-014-0449-4